insights_auto
Why is IOVA up 9.84%?
Dive Deeperchevron_right
IOVA:NASDAQ
Iovance Biotherapeutics Inc
$14.62
arrow_upward
+9.84%(+1.31) 1D
$14.58
arrow_downward
-0.27% (-0.040)todayPre-market
Closed: Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IOVA...
Open
$13.36
High
$14.94
Low
$13.29
Mkt. cap
6.62B
Avg. vol.
16.33M
Volume
9.69K
52-wk high
$15.30
52-wk low
$1.76
EPS
-$0.72
Beta
0.76
Shares outstanding
452.97M
No. of employees
975
Open
$13.36
High
$14.94
Low
$13.29
Mkt. cap
6.62B
Avg. vol.
16.33M
Volume
9.69K
52-wk high
$15.30
52-wk low
$1.76
EPS
-$0.72
Beta
0.76
Shares outstanding
452.97M
No. of employees
975
News stories
From web sources and news partners
Simply Wall Street
·
1 day ago
Why Iovance Biotherapeutics Stock Is In Focus After Revenue Guidance Raise
TipRanks
·
2 days ago
Iovance Expands Lifileucel Into Sarcoma: What SARATOGA Means for Investors
Profile
Iovance Biotherapeutics, Inc. is a biopharmaceutical company based in Philadelphia, Pennsylvania. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
About Iovance Biotherapeutics Inc
CEO-
Employees975
Founded2007
HeadquartersSan Carlos, California, United States
SectorBiotechnology
Websiteiovance.com